Commit To Buy Cara Therapeutics At $5, Earn 15.6% Annualized Using Options
September 27, 2016 at 11:37 AM EDT
Investors considering a purchase of Cara Therapeutics Inc (CARA) stock, but cautious about paying the going market price of $8.37/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $5 strike, which has a bid at the time of this writing of 50 cents..